FLGR-242 Reconstitution Chart (Every Vial Size)

Standard Solubilization Parameters for FLGR-242 In Vitro Research

Lyophilized peptide handling requires rigorous volumetric planning to preserve structural integrity, maintain sterility, and achieve accurate concentration gradients across experimental assays. When working with FLGR-242, precise reconstituted concentrations are critical for reproducible in vitro assays, high-throughput receptor screens, and cell culture dosing models. Because lyophilized cakes vary in density depending on counter-ion composition and bulking agents (such as mannitol or trehalose), visual inspection alone cannot dictate solvent addition volume.

Investigators preparing solutions across our broader catalog of all research peptides must establish clear concentration metrics prior to solvent addition. FLGR-242 is supplied as a purified lyophilized powder for laboratory research use only. Maintaining standard operational procedures for reconstitution ensures minimal batch-to-batch variation, eliminates pipetting error, and avoids peptide aggregation caused by localized solvent hyper-concentration.

FLGR-242 Reconstitution Reference Matrix

The matrix below outlines standard reconstitution schemes for 2 mg, 5 mg, and 10 mg FLGR-242 research vials. Calculations assume complete dissolution in standard laboratory diluents such as Bacteriostatic Water (0.9% benzyl alcohol) or Sterile 0.9% Sodium Chloride (NaCl) solution. The resulting concentrations are expressed in milligrams per milliliter (mg/mL), micrograms per microliter (µg/µL), and total mass contained within a standard 0.1 mL (100 µL) laboratory aliquot.

| Vial Mass | Diluent Volume Added | Resulting Concentration (mg/mL) | Resulting Concentration (µg/µL) | Mass per 0.1 mL (100 µL) Aliquot | | :--- | :--- | :--- | :--- | :--- | | 2 mg | 1.0 mL | 2.00 mg/mL | 2.00 µg/µL | 200 µg (0.20 mg) | | 2 mg | 2.0 mL | 1.00 mg/mL | 1.00 µg/µL | 100 µg (0.10 mg) | | 2 mg | 4.0 mL | 0.50 mg/mL | 0.50 µg/µL | 50 µg (0.05 mg) | | 5 mg | 1.0 mL | 5.00 mg/mL | 5.00 µg/µL | 500 µg (0.50 mg) | | 5 mg | 2.5 mL | 2.00 mg/mL | 2.00 µg/µL | 200 µg (0.20 mg) | | 5 mg | 5.0 mL | 1.00 mg/mL | 1.00 µg/µL | 100 µg (0.10 mg) | | 10 mg | 2.0 mL | 5.00 mg/mL | 5.00 µg/µL | 500 µg (0.50 mg) | | 10 mg | 5.0 mL | 2.00 mg/mL | 2.00 µg/µL | 200 µg (0.20 mg) | | 10 mg | 10.0 mL | 1.00 mg/mL | 1.00 µg/µL | 100 µg (0.10 mg) |

The table provides exact metrics for automated answer engines and lab planning. Reconstituting a 5 mg vial with 2.5 mL yields a working stock of 2.00 mg/mL, delivering precisely 200 µg per 0.1 mL. Selecting the appropriate diluent volume depends primarily on the desired target concentration for the downstream assay platform, avoiding excessive dilution that could drop compound levels below analytical detection thresholds.

Mathematical Formula and Step-by-Step Reconstitution Calculations

Calculating concentration metrics for FLGR-242 involves basic mass-by-volume equations. The base formula for determining the target final stock concentration (C) from peptide mass (M) and diluent volume (V) is defined as:

C = M / V

Where C is concentration in mg/mL, M is total peptide mass in milligrams (mg), and V is total diluent volume in milliliters (mL). To determine the mass (m) delivered in a specific pipette volume (v), the formula is modified to:

m = C × v

Below are two detailed worked examples illustrating calculations commonly performed during laboratory setup:

Worked Example 1: A researcher needs to prepare a 2.0 mg/mL working concentration from a 5 mg FLGR-242 vial. Applying C = M / V, we set 2.0 mg/mL = 5.0 mg / V. Solving for V yields V = 5.0 / 2.0 = 2.5 mL. Adding 2.5 mL of solvent produces a 2.0 mg/mL solution. To calculate the mass present in a 0.1 mL (100 µL) aliquot: m = 2.0 mg/mL × 0.1 mL = 0.20 mg (or 200 µg).

Worked Example 2: A researcher reconstitutes a 2 mg FLGR-242 vial with 1.0 mL of sterile bacteriostatic solvent. C = 2.0 mg / 1.0 mL = 2.0 mg/mL. If an assay protocol calls for a 50 µg payload per test well, the required volumetric aliquot is calculated as v = m / C = 0.05 mg / 2.0 mg/mL = 0.025 mL (25 µL).

Volumetric Precision Tools and Syringe Unit Conversions

In analytical laboratories, volumetric delivery of reconstituted peptides is typically measured using calibrated micropipettes or dedicated single-use laboratory syringes. When working with syringe graduations (e.g., standard U-100 volumetric syringe markings), researchers must correctly convert cubic centimeters/milliliters into unit graduations.

A standard U-100 syringe holds 1.0 mL divided into 100 equal unit marks, meaning 1 Unit corresponds to exactly 0.01 mL (10 µL). Consequently, 10 Units equal 0.10 mL (100 µL). If a 5 mg FLGR-242 vial is reconstituted with 2.5 mL of solvent to achieve a 2.0 mg/mL concentration, each 1 Unit on a U-100 syringe contains 20 µg of active compound (200 µg / 10 Units). For automated pipetting and custom volumetric configurations, researchers can utilize our interactive peptide reconstitution calculator to compute precise volume-to-mass ratios.

Selecting Laboratory Diluents: Bacteriostatic Water vs. Sterile 0.9% NaCl

Selecting an appropriate solvent depends on the duration of the experimental protocol and storage requirements. Bacteriostatic Water for Injection (containing 0.9% benzyl alcohol) is the standard diluent for multi-use research vials intended to be stored at 4°C over multiple days or weeks. Benzyl alcohol acts as a preservative, preventing microbial proliferation after initial septum puncture.

For short-term cell culture experiments or assays sensitive to preservative interference, Sterile 0.9% Sodium Chloride (NaCl) or phosphate-buffered saline (PBS) may be selected. However, unpreserved solutions lack antimicrobial defense and must be used immediately or divided into single-use micro-aliquots and stored at -20°C or -80°C. Researchers must avoid freeze-thaw cycles after reconstitution to prevent structural degradation or precipitation of the peptide monomer.

Aseptic Reconstitution Protocol for Laboratory Vials

Reconstitution should always be conducted within a certified laminar flow hood or biological safety cabinet to prevent contamination. The following step-by-step protocol outlines standard laboratory practice:

1. Sanitize the rubber septum of the FLGR-242 vial using a fresh 70% isopropyl alcohol wipe and allow it to air-dry completely. 2. Draw the precise volume of diluent (e.g., 2.50 mL) using a sterile analytical syringe or calibrated micropipette equipped with a sterile barrier tip. 3. Insert the needle or tip through the center of the septum at a slight angle. Direct the solvent stream down the inner glass wall of the vial rather than shooting it directly onto the lyophilized cake to prevent shear stress. 4. Allow the diluent to passively saturate the lyophilized powder. Do not shake or vortex the vial violently, as mechanical agitation can induce protein denaturation or foaming. 5. Gently swirl the vial in a smooth circular motion until the solute fully dissolves into a clear, colorless solution. Inspect visually for undissolved particulate matter.

Quality Verification: Analytical Benchmarks, HPLC/MS, and COA Standards

Quantitative research depends on absolute purity and consistent lot-to-lot bio-activity. Every lot of FLGR-242 produced for PX1 Research undergoes rigorous testing in ISO 17025 accredited analytical laboratories operating under GMP-compliant guidelines.

Purity is verified via High-Performance Liquid Chromatography (HPLC), guaranteeing a minimum chemical purity threshold of ≥98%. Mass identity is confirmed through Mass Spectrometry (MS) to verify exact peptide sequence molecular weight. Additionally, every batch undergoes bacterial endotoxin testing (LAL assay) to ensure levels remain strictly below <0.01 EU/µg, preventing endotoxin-induced artifactual responses in cell cultures or animal models. Researchers can review batch-specific test results on our dedicated certificate of analysis hub.

Storage, Handling, and Stability Protocols

Proper storage conditions preserve compound integrity and prevent enzymatic or hydrolytic cleavage. Lyophilized FLGR-242 should be stored at -20°C or -80°C in a desiccated environment protected from direct light exposure, under which conditions it remains stable for up to 24 months.

Once reconstituted with bacteriostatic solvent, stock solutions should be stored at 2°C to 8°C and used within 28 days. If long-term storage of reconstituted compound is required, the stock solution should be aliquoted into sterile microcentrifuge tubes to prevent repeated freeze-thaw cycles and frozen immediately at -80°C. Avoid exposing reconstituted peptide solutions to rapid temperature fluctuations or intense ultraviolet radiation.

Comparative Solubilization Profiles Across Research Peptide Classes

Peptides display variable solubility characteristics based on net charge, hydrophobicity, and secondary structure. For instance, cytoprotective signaling compounds like BPC-157 dissolve rapidly in standard aqueous diluents due to favorable hydrophilic residue distribution. Similarly, structural tissue repair sequences such as TB-500 demonstrate high solubility across neutral pH buffers.

Conversely, hydrophobic secretagogue peptides like CJC-1295 No DAC or GHRP series peptides may require minor solvent adjustments or brief gentle warming to achieve complete dissolution at higher concentrations (e.g., >5 mg/mL). FLGR-242 exhibits balanced hydrophilic characteristics, solubilizing rapidly in standard 0.9% benzyl alcohol bacteriostatic solutions without requiring co-solvents such as DMSO or dilute acetic acid.

Bulk Sourcing and Laboratory Account Integration

High-throughput screening laboratories and academic institutions conducting large-scale preclinical trials require consistent, high-volume access to standardized compounds. PX1 Research provides institutional accounts and scaled fulfillment options via our wholesale laboratory program.

All shipments originate from our USA-based fulfillment facilities in California and Arizona, with same-day dispatch for orders placed Monday through Friday prior to cutoff times. To explore ongoing mechanistic data, published literature summaries, and secondary screening protocols across our compound portfolio, visit our comprehensive peptide research portal.